Vaccine News and Research

Latest Vaccine News and Research

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

A recent study, currently available on the medRxiv* preprint server, has shown how longer dosing intervals of vaccines against coronavirus disease (COVID-19) may be able to minimize mortality in low- and middle-income countries in the WHO European region – and significantly change our vaccination strategy.

30 Nov 2021

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.

30 Nov 2021

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

As the COVID-19 pandemic nears the two-year mark, Northwestern Medicine scientists continue to tackle every facet of the disease, from investigating coronavirus vaccines' potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.

30 Nov 2021

COVID-19 booster jabs to be offered to all adults in England by the end of January

All eligible adults in England aged 18 and over will be offered a COVID-19 booster vaccine by the end of January.

30 Nov 2021

Omicron and other coronavirus variants: What you need to know

Americans, already weary of a pandemic nearly two years long, were dealt a new blow during the long Thanksgiving weekend: the announcement that a new coronavirus variant had emerged.

30 Nov 2021

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Researchers from the University of Michigan investigated the correlation between SARS-CoV-2 infection and the severity of reinfections.

30 Nov 2021

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Researchers from the University of Sydney investigate the genomic variability of SARS-CoV-2 within the host and in vitro.

30 Nov 2021

From tiny particles to big success: Knauer awarded the innovation prize for Berlin Brandenburg

The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the prestigious Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs).

From KNAUER Wissenschaftliche Geräte GmbH 30 Nov 2021

Scientists develop a smartwatch-based device for early detection of COVID-19

Scientists have developed a wearable device that can detect the early onset of COVID-19 in real-time by analyzing the aberrant changes in physiological parameters caused by SARS-CoV-2 infection.

30 Nov 2021

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

Research suggests that COVID-19 from Delta or Alpha infections is clinically similar, yet Delta is more transmissible than Alpha.

30 Nov 2021

With federal covid sick leave gone, workers feel pressure to show up at work

Economists and public health experts alike say paid sick leave is an essential tool — like testing, masks and vaccines — in the effort to prevent covid-19 infection and keep workplaces safe.

30 Nov 2021

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.

30 Nov 2021

Increased illness burden of COVID-19 among unvaccinated first responders

A new study gathered data from the HEROES-RECOVER prospective cohorts and reported an increased illness burden of COVID-19 among unvaccinated first responders.

30 Nov 2021

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

A new study aimed to identify COVID-19 vaccination coverage, examine the factors responsible for COVID-19 vaccination coverage and vaccine hesitancy, study adverse events following immunization patterns after COVID-19 vaccination and determine the prevalence of breakthrough infection after COVID-19 vaccination.

30 Nov 2021

Targeted measures to prevent the spread of Omicron variant take effect from 30 November 2021

Targeted measures to prevent the spread of the new COVID-19 Omicron variant take effect from 4am today [Tuesday 30 November].

29 Nov 2021

Novel influenza vaccine candidate shows promise

Researchers investigate the potential value of a new vaccine candidate for the influenza virus.

29 Nov 2021

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Researchers attempt to predict future transmission rates by identifying multiple scenarios that could occur over the next year.

29 Nov 2021

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

On 8-10 November 2021, Dr Naveen Rao, Senior Vice President, Health and other senior representatives from The Rockefeller Foundation joined World Health Organization representatives to review the strategic directions of collaboration between the two Organizations.

29 Nov 2021

AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa

Building on lessons learned from our collective experience with dose donations over the past several months, the African Vaccine Acquisition Trust, the Africa Centres for Disease Control and Prevention and COVAX wish to draw the attention of the international community to the situation of donations of COVID-19 vaccines to Africa, and other COVAX participating economies, particularly those supported by the Gavi COVAX Advance Market Commitment.

29 Nov 2021

CDC strengthens recommendation on COVID-19 booster doses

Today, CDC is strengthening its recommendation on booster doses for individuals who are 18 years and older. Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.

29 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

Longer between-dose intervals for COVID-19 vaccines may significantly reduce mortality

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

COVID-19 booster jabs to be offered to all adults in England by the end of January

Omicron and other coronavirus variants: What you need to know

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Host and in vitro genomic variability of SARS-CoV-2 and its variants

From tiny particles to big success: Knauer awarded the innovation prize for Berlin Brandenburg

Scientists develop a smartwatch-based device for early detection of COVID-19

UK study finds COVID-19 from Delta and Alpha infections are clinically similar

With federal covid sick leave gone, workers feel pressure to show up at work

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

Increased illness burden of COVID-19 among unvaccinated first responders

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

Targeted measures to prevent the spread of Omicron variant take effect from 30 November 2021

Novel influenza vaccine candidate shows promise

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa

CDC strengthens recommendation on COVID-19 booster doses

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in